LE RISQUE DE TUBERCULOSE DANS DES MILIEUX EXPOSES A UNE SURINFECTION CONSTANTE AVEC DES BACILLES TUBERCULEUX INH-SENSIBLES ET INH-RESISTANTSTELEJKO Z.1972; GRUZLICA CHOR. PLUC; POLSKA; DA. 1972; VOL. 40; NO 7; PP. 591-598; ABS. RUSSE ANGL.; BIBL. 7REF.Serial Issue

Chemiluminescence detection of isoniazid using Ru(phen)₃²⁺-isoniazid-Ce(IV) systemJUAN XI; BO'AN SHI; XINPING AI et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 36, Num 1, pp 237-241, issn 0731-7085, 5 p.Article

PERINATAL CARCINOGENICITY OF IONIAZID (INH) IN SWISS MICEMENON MM; BHIDE SV.1983; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1983; VOL. 105; NO 3; PP. 258-261; BIBL. 20 REF.Article

PLANIFICATION DE L'EXPERIENCE LORS DE L'EVALUATION DES CONDITIONS OPTIMALES DE DETERMINATION QUANTITATIVE DE L'ISONIAZIDECHEKRYSHKINA LA.1974; FARMACIJA; S.S.S.R.; DA. 1974; VOL. 23; NO 4; PP. 44-46; ABS. ANGL.Article

SYNTHESE DE L'ISONIAZIDE A PARTIR DE LA CYANO-4 PYRIDINESYCHEVA TP; PAVLOVA TN; SHCHUKINA MN et al.1972; KHIMIKO-FARM. ZH.; S.S.S.R.; DA. 1972; VOL. 6; NO 11; PP. 6-8; BIBL. 7REF.Serial Issue

PREVENTIVE TREATMENT OF UNTREATED, NONACTIVE TUBERCULOSIS IN AN ESKIMO POPULATIONCOMSTOCK GW; WOOLPERT SF.1972; ARCH. ENVIRONMENT. HEALTH; U.S.A.; DA. 1972; VOL. 25; NO 5; PP. 333-337; BIBL. 11REF.Serial Issue

Mutational and expression analysis of tbnat and its response to isoniazidSHOLTO-DOUGLAS-VERNON, Carolyn; SANDY, James; VICTOR, Thomas C et al.Journal of medical microbiology. 2005, Vol 54, Num 12, pp 1189-1197, issn 0022-2615, 9 p.Article

AN EVALUATION OF THE FLUOROMETRIC DETERMINATION OF ISONICOTINIC ACID HYDRAZIDEO'BARR TP; KEITH DJ; BLAIR EB et al.1973; AMER. REV. RESP. DIS.; U.S.A.; DA. 1973; VOL. 107; NO 3; PP. 472-474; BIBL. 5REF.Serial Issue

Study of the interaction between rifapentine and isoniazid under acid conditionsPRASAD, Bhagwat; BHUTANI, Hemant; SINGH, Saranjit et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 4, pp 1438-1441, issn 0731-7085, 4 p.Article

Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?KINZIG-SCHIPPERS, Martina; TOMALIK-SCHARTE, Dorota; JETTER, Alexander et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 5, pp 1733-1738, issn 0066-4804, 6 p.Article

In vitro studies on the release of isoniazid incorporated in poly(ε-Caprolactone)DURAN, N; DE OLIVEIRA, A. F; DE AZEVEDO, M. M. M et al.Journal of chemotherapy. 2006, Vol 18, Num 5, pp 473-479, issn 1120-009X, 7 p.Article

CHLORAMINE-T AS TITRIMETRIC REAGENT IN POTENTIOMETRIC DETERMINATION OF ISONIAZID, PHENELZINE, AND DIHYDRALAZINE = LA CHLORAMINE T EN TANT QUE REACTIF TITRIMETRIQUE DANS LA DETERMINATION POTENTIOMETRIQUE DE L'ISONIAZIDE, DE LA PHENELZINE ET DE LA DIHYDRALAZINEPINZAUTI S; DAL PIAZ V; LA PORTA E et al.1974; J. PHARM. SCI.; U.S.A.; DA. 1974; VOL. 63; NO 9; PP. 1446-1448; BIBL. 20REF.Article

SCREENING OF ISONIAZID INACTIVATORS BY DILUTION TEST.HODGKIN MM; EIDUS L; HAMILTON EJ et al.1974; BULL. ORGANIS. MOND. SANTE; SUISSE; DA. 1974; VOL. 51; NO 4; PP. 428-430; BIBL. 10 REF.Article

AN ACQUIRED INHIBITOR OF FIBRIN STABILIZATION ASSOCIATED WITH ISONIAZID THERAPY: CLINICAL AND BIOCHEMICAL OBSERVATIONS = UN INHIBITEUR ACQUIS DE LA STABILISATION DE LA FIBRINE ASSOCIE AU TRAITEMENT PAR L'ISONIAZIDE: OBSERVATIONS CLINIQUES ET BIOCHIMIQUESOTIS PT; FEINSTEIN DI; RAPAPORT SI et al.1974; BLOOD; U.S.A.; DA. 1974; VOL. 44; NO 6; PP. 771-781; BIBL. 21REF.Article

BIO-AVAILABILITY OF INH IN LIQUID DOSAGE FORM = BIODISPONIBILITE DE L'ISONIAZIDE EN SOLUTIONCHAVAN SR; NIKAM ST; PRADHAN DV et al.1974; INDIAN J. PHYSIOL. PHARMACOL.; INDIA; DA. 1974; VOL. 18; NO 2; PP. 120-122; BIBL. 4REF.Article

MUTAGENIC ACTIVITY OF ISONIAZID AND HYDRAZINE IN MAMMALIAN TEST SYSTEMS = ACTIVITE MUTAGENE DE L'ISONIAZIDE ET DE L'HYDRAZINE DANS DES SYSTEMES TESTS DE MAMMIFERESROEHRBORN G; PROPPING P; BUSELMAIER W et al.1972; MUTATION RES.; NETHERL.; DA. 1972; VOL. 16; NO 2; PP. 189-194; BIBL. 1 P.Serial Issue

Isoniazid acetylation phenotyping in Saudi ArabsMATAR, K. M; MAYET, A. Y; AYOOLA, E. A et al.Journal of clinical pharmacy and therapeutics (Print). 2004, Vol 29, Num 5, pp 443-447, issn 0269-4727, 5 p.Article

DETERMINATION OF ACETYLATOR PHENOTYPE BASED ON THE RATIO OF ACETYLISONIAZID TO ISONIAZID IN URINE FOLLOWING AN ORAL DOSE OF ORDINARY ISONIAZIDRAGHUPATI SARMA G; KANNAPIRAN M; NARAYANA ASL et al.1976; INDIAN J. MED. RES.; INDIA; DA. 1976; VOL. 64; NO 1; PP. 1-8; BIBL. 1 P.Article

Amperometric determination of isoniazid in a flowing stream at the glassy carbon electrodeSHAH, M. H; STEWART, J. T.Analytical letters. 1983, Vol 16, Num 12, pp 913-923, issn 0003-2719Article

DETERMINATION OF HYDRAZINE METABOLITES OF ISONIAZID IN HUMAN URINE BY GAS CHROMATOGRAPHY.TIMBRELL JA; WRIGHT JM; SMITH CM et al.1977; J. CHROMATOGR.; NETHERL.; DA. 1977; VOL. 138; NO 1; PP. 165-172; BIBL. 13 REF.Article

ON THE SYNTHESIS AND PROPERTIES OF SOME COMPLEXES BENZOATE OF DRUGS USED IN TUBERCULOSIS'S THERAPY (INH, EPH, IPH)DOADRIO A; CRACIUNESCU D; SUAREZ M et al.1976; FARM. AIKAKAUSLEHTI; SUOMI; DA. 1976; VOL. 85; NO 1; PP. 19-27; BIBL. 21 REF.Article

THE INSTABILITY OF ISONIAZID AND ACETYLISONIAZID IN FROZEN PLASMA.HUFFMAN DH; DUJOVNE CA.1976; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1976; VOL. 15; NO 1; PP. 203-204; BIBL. 3 REF.Article

ON THE THIOCYANATE-ISOTHIOCYANATE AND SELENOCYANATE-ISOSELENOCYANATE ISOMERISM IN THE COMPLEXES FORMED BY DRUGS EMPLOYED IN THE TUBERCULOSIS' THERAPY, WITH TRANSITION METALSCRACIUNESCU D; DOADRIO A; HURTADO MI et al.1975; FARM. AIKAKAUSLEHTI; SUOMI; DA. 1975; VOL. 84; NO 3; PP. 125-134; BIBL. 18 REF.Article

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis InfectionSTERLING, Timothy R; VILLARINO, M. Elsa; WEIS, Stephen E et al.The New England journal of medicine. 2011, Vol 365, Num 23, pp 2155-2166, issn 0028-4793, 12 p.Article

An explanation for the physical instability of a marketed fixed dose combination (FDC) formulation containing isoniazid and ethambutol and proposed solutionsBHUTANI, Hemant; MARIAPPAN, T. T; SINGH, Saranjit et al.Drug development and industrial pharmacy. 2004, Vol 30, Num 6, pp 667-672, issn 0363-9045, 6 p.Article